About Us

iPierian is a pioneering biopharmaceutical company that is harnessing the power of induced pluripotent stem cells to advance the understanding of human diseases and accelerate the discovery of more effective therapeutics for patients. iPierian has built one of the most qualified teams of stem cell scientists in the world, combining the expertise of the founding scientists with internationally-renowned scientists from top institutions such as the Harvard Stem Cell Institute, University of California San Francisco, Kyoto University, among others. iPierian is the first company to apply cellular reprogramming and directed differentiation to cells that are derived from patients representing a broad spectrum of diseases. iPierian will apply its technology to recapitulate human disease in vitro, enabling the discovery of novel targets and disease-modifying therapeutics. iPierian is focusing on neurological diseases – such as Spinal Muscular Atrophy, Amyotrophic Lateral Sclerosis, and Alzheimer’s disease. In addition to developing its own proprietary pipeline, iPierian will also collaborate with pharmaceutical and biotechnology industry partners.